Navigation Links
Aethlon Medical Announces Multi-Target Exosome Assay Validation
Date:4/12/2011

ither internally or through outside companies and to create future generations of the Hemopurifier®, the impact of government regulations, patent protection on the Company's proprietary technology, product liability exposure, uncertainty of market acceptance, competition, technological change, and other risk factors. In such instances, actual results could differ materially as a result of a variety of factors, including the risks associated with the effect of changing economic conditions and other risk factors detailed in the Company's Securities and Exchange Commission filings.

Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com

John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com


'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Aethlon Medical Releases Shareholder Letter
2. Aethlon Medical Receives FDA Approval to Export its Hemopurifier® to India
3. Aethlon Medical Releases Shareholder Letter
4. Aethlon Medical to Host Investor Event on January 20, 2011
5. Aethlon Medical Announces Presentation at U.S. Department of Health and Human Services BARDA Industry Day
6. A Platform Technology to Address Bioterrorism Released by Aethlon Medical, Inc.
7. Aethlon Medical to Present at the Singular Research Fifth Annual Best of the Uncovereds Conference
8. Aethlon Medical Names Rod Kenley President
9. Aethlon Medical Announces Appointment of Rod Kenley to Its Board of Directors
10. Aethlon Medical Engages Fabiani & Company to Advance U.S. Government Partnerships
11. Aethlon Medical Reestablishes Biodefense Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015 Jintian Pharmaceutical Group Limited ("Jintian Pharmaceutical" ... Jin Dongtao, chairman and executive director purchased 40,000,000 ordinary ... the existing entire issued share capital of the Company ... the total amount of approximately HK$113 million. Upon the ... increase from 45.17% to 47.17%. Mr. ...
(Date:4/1/2015)... 30, 2015 Research and Markets ( ... "An Introduction to the Medical Device Directives" conference ... detailed introduction to the European medical device legislation. It ... the involvement of Notified Bodies, how to choose one ... also cover the documentation necessary to apply for the ...
(Date:4/1/2015)... 2015  Philips Respironics, a division of Royal Philips ... Pico nasal mask is now available in ... obstructive sleep apnea (OSA). Designed to maximize comfort and effectiveness, ... pressure (CPAP) mask available on the market to treat OSA*. ... will be on display at Medtrade Spring (Booth ...
Breaking Medicine Technology:Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2Philips Pico CPAP Nasal Mask Now Available in the United States 2Philips Pico CPAP Nasal Mask Now Available in the United States 3
... by FDA for long-term maintenance,treatment of COPD ... improved lung function,comparable to dry powder formoterol, ... profile --, NAPA, Calif., May 20, 2007 ... of the American Thoracic Society (ATS),demonstrate that ...
... Also Show Nebivolol Lowers Blood Pressure in ... 2007 /PRNewswire-FirstCall/ -- Forest,Laboratories, Inc. today presented ... pooled analysis of nebivolol, a selective beta,1-blocker ... U.S. Food and Drug Administration (FDA) for ...
Cached Medicine Technology:Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 2Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 3Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 4Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 5Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 6Clinical Trial Data for Perforomist (Formoterol Fumarate),Inhalation Solution Presented at International ATS Conference 7Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 2Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 3Data Presented at ASH Demonstrate Nebivolol Lowers Blood Pressure,as Long-Term Monotherapy and in Combination Therapy 4
(Date:4/1/2015)... 2015 This year for Oral Cancer Awareness ... Foundation for an Open House to offer complimentary oral cancer ... 4 p.m. An appointment is required and can be secured ... at 212-689-0024. In addition, Herald Square Dental and The Denture ... month of April at the reduced cost of $39 (regularly ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 The Path Adventures ... extreme jungle adventure you could ever embark upon. Trips range ... Endorsed by the Philippine Department of Tourism, these trips are ... rainforest, but very few people have ever been in virgin ... , Armed with nothing more than a backpack full of ...
(Date:4/1/2015)... New York, New York (PRWEB) April 01, 2015 ... litigation housing hundreds of Risperdal lawsuits ( http://www.risperdallawsuit2014.com/ ... According to the calendar for the Philadelphia Court of ... in Court Room 206, City Hall. Court records indicate ... liability claims filed on behalf of Risperdal users who ...
(Date:4/1/2015)... April 01, 2015 SCI Solutions ... scheduling platform, today announced that CEO Joel French will ... HIMSS Conference & Exhibition in Chicago, April 12-16, ... with Better Provider Care Coordination Strategies ” with Northeast ... 12 p.m. CDT. More than 38,000 healthcare industry professionals ...
(Date:4/1/2015)... Peoria, Ill. (PRWEB) April 01, 2015 ... the OSF Healthcare System , was welcomed into ... Dedication Ceremony officiated by Msgr. Paul E. Showalter, vicar ... , The Blessing and Dedication culminated a nearly year-long ... the eleventh OSF HealthCare hospital. Speakers for the morning ...
Breaking Medicine News(10 mins):Health News:Herald Square Dental Celebrates Oral Cancer Awareness Month 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 2Health News:Pennsylvania Court Overseeing Hundreds of Risperdal Lawsuits Schedules April Meeting 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 2Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 3Health News:SCI Solutions CEO Joel French and Northeast Georgia Health System to Present at HIMSS15 4Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3
... now help detection of Neurological disorders in their ... any of them//. ,Melbourne researchers have found ... as coffee, whisky, roses and bleach and neurological ... ,Scientific director of the Melbourne Neuropsychiatry Clinic, ...
... known to have healing properties. It was earlier considered ... of telomerase expressed were// related but it is now ... increase the rate of cancer. ,Vera Gorbunova, ... conducted a first-of-its-kind study to discover why some animals ...
... is a new tool developed by researchers at Greene ... Public Health// and ,their colleagues in the WHO Global ... first tool to provide comprehensive, differential diagnosis of infectious ... parasites. In addition, it is the first tool that ...
... modified fats rich in cholesterol and known to cause heart ... fats in bakery products//, fried foods like chips, salad dressings ... is also believed to have a longer shelf life. ... members of the New York City Board of Health, voted ...
... hope in patients suffering Parkinson’s disease, with transplanted neural ... cells., ,Cesario Borlongan of the Medical College of ... human neural stem cell transplant that is capable of ... control, which is the typical characteristic of the disease. ...
... very extensive research that spanned over 3 decades was ... women stand the risk of mental illnesses such as ... delivery. Women without children were seldom seen admitted in ... four times more risk than those who do not ...
Cached Medicine News:Health News:Detection of Neurological Disorder is Just a Sniff Away!! 2Health News:Telomerase Expression Linked To Body Mass 2Health News:Telomerase Expression Linked To Body Mass 3Health News:The GreeneChip- First Tool to Provide Differential Diagnosis of Infectious Diseases 2Health News:The GreeneChip- First Tool to Provide Differential Diagnosis of Infectious Diseases 3Health News:Ban On Trans Fats Comes Into Effect From July 1 2
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: